GlaxoSmithKline Historical Balance Sheet

<div class='circular--portrait' style='background:#754DEB;color: #F0FFF0;font-size:4em;padding-top: 25px;;'>GP</div>
GSK -- USA Stock  

Report: 22nd of July 2020  

Trend analysis of GlaxoSmithKline PLC balance sheet accounts such as Accounts Payable of 3.5 B or Total Assets of 71.3 B provides information on GlaxoSmithKline PLC total assets, its liabilities, and its equity, which is the actual value of GlaxoSmithKline PLC to its prevalent stockholders. By breaking down trends over time using GlaxoSmithKline PLC balance sheet statements, investors will see what exactly the company owned and what it owed to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down GlaxoSmithKline PLC prevalent accounting reports in order to predict its past. Macroaxis encourages investors to analyze financial statement over time for various trends across multiple indicators and accounts to determine whether GlaxoSmithKline PLC is a good buy for the upcoming year. Please check Risk vs Return Analysis.

Search Historical Statements


About GlaxoSmithKline Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of GlaxoSmithKline PLC at a specified time, usually calculated after every quarter, six months, or one year. GlaxoSmithKline PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of GlaxoSmithKline PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which GlaxoSmithKline currently owns. An asset can also be divided into two categories, current and non-current.

GlaxoSmithKline PLC Balance Sheet Chart

GlaxoSmithKline PLC Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how GlaxoSmithKline PLC uses and utilizes its capital. It also shows what exactly a company owns and owes. GlaxoSmithKline PLC Property Plant and Equipment Net is increasing as compared to previous years. The last year's value of Property Plant and Equipment Net was reported at 11.31 Billion. The current Accumulated Retained Earnings Deficit is estimated to increase to about 4.9 B, while Accounts Payable is estimated to decrease to under 3.5 B.
Add Fundamental

Total Assets

Total assets refers to the total amount of GlaxoSmithKline PLC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GlaxoSmithKline PLC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.

Current Assets

Current assets of GlaxoSmithKline PLC include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of GlaxoSmithKline PLC. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Assets Non Current

Amount of non-current assets; for companies that operate a classified balance sheet. Calculated as the different between Total Assets Total Assets and Current Assets Current Assets.

Cash and Equivalents

A component of Total Assets representing the amount of currency on hand as well as demand deposits with banks or financial institutions.
Most accounts from GlaxoSmithKline PLC balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into GlaxoSmithKline PLC current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.GlaxoSmithKline PLC Property Plant and Equipment Net is increasing as compared to previous years. The last year's value of Property Plant and Equipment Net was reported at 11.31 Billion. The current Accumulated Retained Earnings Deficit is estimated to increase to about 4.9 B, while Accounts Payable is estimated to decrease to under 3.5 B.
 2017 2018 2019 2020 (projected)
Receivables5.67 B6.08 B6.87 B5.97 B
Inventories5.56 B5.48 B5.95 B5.09 B

GlaxoSmithKline PLC balance sheet Correlations

Click cells to compare fundamentals   Check VolatilityBacktest Portfolio

GlaxoSmithKline PLC Account Relationship Matchups

GlaxoSmithKline PLC balance sheet Accounts

2014201520162017201820192020 (projected)
Inventories4.23 B4.72 B5.1 B5.56 B5.48 B5.95 B5.09 B
Receivables4.32 B5.27 B5.67 B5.67 B6.08 B6.87 B5.97 B
Accounts Payable2.79 B3.12 B3.6 B3.53 B3.65 B4.14 B3.48 B
Total Assets40.65 B53.45 B59.08 B56.38 B58.07 B79.69 B71.26 B
Current Assets14.68 B16.59 B16.71 B15.91 B16.93 B19.49 B19.68 B
Assets Non Current25.97 B36.86 B42.37 B40.47 B41.14 B60.2 B51.58 B
Cash and Equivalents4.34 B5.83 B4.9 B3.83 B3.87 B4.71 B4.6 B
Cash and Equivalents USD6.76 B8.59 B6.05 B5.18 B4.92 B6.19 B6.42 B
Total Debt18.78 B16.63 B18.79 B17.09 B26.06 B30.51 B27.14 B
Debt Current2.94 B1.31 B4.13 B2.83 B5.79 B6.92 B5.47 B
Debt Non Current15.84 B15.32 B14.66 B14.26 B20.27 B23.59 B21.67 B
Total Debt USD29.26 B24.52 B23.21 B23.09 B33.08 B40.14 B37.24 B
Shareholders Equity4.26 B5.11 B1.12 B(68 M)3.78 B11.4 B12.31 B
Shareholders Equity USD6.64 B7.54 B1.39 B(91.87 M)4.8 B15.01 B16.19 B
Goodwill and Intangible Assets12.04 B21.83 B24.74 B23.3 B22.99 B41.52 B32.89 B
Inventory4.23 B4.72 B5.1 B5.56 B5.48 B5.95 B5.8 B
Investments1.52 B1.54 B1.34 B1.18 B1.64 B2.23 B2.09 B
Investments Current69 M75 M89 M78 M84 M79 M89.69 M
Investments Non Current1.45 B1.46 B1.25 B1.1 B1.56 B2.15 B1.98 B
Total Liabilities35.72 B44.57 B54.12 B52.89 B54.39 B61.34 B56.96 B
Current Liabilities13.29 B13.42 B19 B26.57 B22.49 B24.05 B22.46 B
Liabilities Non Current22.42 B31.15 B35.12 B26.32 B31.9 B37.28 B34.5 B
Trade and Non Trade Payables7.96 B8.88 B11.96 B20.97 B14.04 B14.94 B13.98 B
Property Plant and Equipment Net9.05 B9.67 B10.81 B10.86 B11.06 B11.31 B11.62 B
Trade and Non Trade Receivables4.6 B5.62 B6.03 B6 B6.42 B7.2 B7.18 B
Accumulated Retained Earnings Deficit(2.07 B)(1.4 B)(5.39 B)(6.48 B)(2.72 B)4.53 B4.89 B
Tax Assets2.83 B3.08 B4.6 B4.05 B4.12 B4.36 B4.17 B
Tax Liabilities1.39 B2.94 B3.24 B2.8 B2.39 B4.63 B3.92 B
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page